Detection of MUM1/IRF4-IgH fusion in multiple myeloma

被引:56
|
作者
Yoshida, S
Nakazawa, N
Iida, S
Hayami, Y
Sato, S
Wakita, A
Shimizu, S
Taniwaki, M
Ueda, R
机构
[1] Nagoya City Univ, Sch Med, Dept Internal Med 2, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan
[3] Shimane Prefectural Cent Hosp, Izumo, Shimane, Japan
关键词
MUM1/IRF4; multiple myeloma; t(6; 14)(p25; q32); IgH insertion; FISH; PFGE;
D O I
10.1038/sj.leu.2401563
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) gene has been identified as an oncogene transcriptionally activated by t(6;14)(p25;q32) chromosomal translocation in multiple myeloma (MFA). The significance of this alteration in MM remains unknown, as it is not detectable by means of conventional cytogenetic analysis. To address this issue, we established diagnostic procedures based on pulsed-field gel electrophoresis (PFGE) analysis and double color fluorescence in site hybridization (DCFISH) using DNA probes derived from the MUM1 and the immunoglobulin heavy chain (IgH) gene loci. Among a panel of 17 MM cell lines, three (17.6%) showed fusions between these two loci, which resulted in the juxtaposition of the MUM1 to the IgH 3' alpha-enhancer region by virtue of t(6;14) or insertion of the IgH sequences into the vicinity of the MUM1 gene and in the concomitant overexpression of the MUM1 mRNA. With similar results, fusions between MUM1 and IgH loci were observed by means of interphase DCFISH in eight (21.1%) out of the 38 MM cases, although no definite relationships between MUM1 status and specific clinical findings could be established.
引用
收藏
页码:1812 / 1816
页数:5
相关论文
共 50 条
  • [31] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    LABORATORY INVESTIGATION, 2002, 82 (01) : 267A - 267A
  • [32] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Trzpuc, T
    Kampalath, B
    Abed, N
    Shidham, V
    Rao, A
    Nagargoje, G
    Chang, C
    MODERN PATHOLOGY, 2002, 15 (01) : 267A - 267A
  • [33] MUM1/IRF4 Is Expressed in a Subset of Follicular Lymphoma with BCL6 Translocation and Short Survival
    Rogers, H. J.
    Bodo, J.
    Jin, T.
    O'Brien, T. E.
    Hsi, E. D.
    LABORATORY INVESTIGATION, 2009, 89 : 283A - 283A
  • [34] Expression and significance of MUM1/IRF4 protein in Hodgkin's and non Hodgkin's lymphoma.
    Graber, MW
    Depowski, PL
    Purdy, S
    Ross, JS
    Nazeer, T
    MODERN PATHOLOGY, 2001, 14 (01) : 165A - 165A
  • [35] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Nagargoje, G
    Trzpuc, T
    Kampalath, B
    Abed, N
    Lorek, J
    Chang, C
    BLOOD, 2001, 98 (11) : 333A - 333A
  • [36] MUM1/IRF4 immunolabeling of neoplastic Langerhans histiocytes in a putative case of canine Langerhans cell histiocytosis
    Klosowski, Marika L.
    Hughes, Kelly L.
    Moore, A. Russell
    VETERINARY CLINICAL PATHOLOGY, 2023, : 670 - 675
  • [37] Impact of IRF4/MUM1 Expression on Adult T-Cell Leukemia/Lymphoma and Treatment Outcome
    Castillo, Luis E. Malpica
    Campuzano-Zuluaga, German
    Toomey, Ngoc L.
    Pimentel, Agustin
    Chapman-Fredricks, Jennifer Rose
    Ramos, Juan Carlos
    BLOOD, 2017, 130
  • [38] Expression and significance of MUM1/IRF4 protein in Hodgkin's and non Hodgkin's lymphoma.
    Graber, MW
    Depowski, PL
    Purdy, S
    Ross, JS
    Nazeer, T
    LABORATORY INVESTIGATION, 2001, 81 (01) : 165A - 165A
  • [39] MUM1/IRF4 Is Expressed in a Subset of Follicular Lymphoma with BCL6 Translocat and Short Survival
    Rogers, H. J.
    Bodo, J.
    Jin, T.
    O'Brien, T. E.
    Hsi, E. D.
    MODERN PATHOLOGY, 2009, 22 : 283A - 283A
  • [40] Anaplastic multiple myeloma with amplification of the IGH-CCND1 gene fusion
    Alencar, Rafael Nobrega
    Martinez, Gracia Aparecida
    Cordeiro, Maria Gabriella
    Velloso, Elvira D. R. P.
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (04) : 495 - 498